Plexus (NASDAQ:PLXS) Issues Earnings Results

Plexus (NASDAQ:PLXS) issued its earnings results on Wednesday. The technology company reported $1.85 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.30, Briefing.com reports. Plexus had a net margin of 2.82% and a return on equity of 9.64%. The business had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.01 billion. During the same period last year, the company posted $1.44 earnings per share. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. Plexus updated its Q1 guidance to $1.52-$1.67 EPS and its Q1 2025 guidance to 1.520-1.670 EPS.

Plexus Stock Down 2.6 %

Shares of NASDAQ:PLXS traded down $3.70 on Friday, reaching $141.19. The company had a trading volume of 318,082 shares, compared to its average volume of 128,867. The company has a current ratio of 1.47, a quick ratio of 0.64 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $3.84 billion, a PE ratio of 35.56 and a beta of 0.89. Plexus has a 52-week low of $88.57 and a 52-week high of $153.60. The firm’s 50 day simple moving average is $130.82 and its 200-day simple moving average is $116.13.

Wall Street Analysts Forecast Growth

Several research firms have commented on PLXS. Benchmark restated a “buy” rating and set a $150.00 price objective on shares of Plexus in a report on Monday. KeyCorp began coverage on Plexus in a research note on Tuesday. They set a “sector weight” rating on the stock. Finally, Needham & Company LLC upped their price objective on shares of Plexus from $144.00 to $162.00 and gave the stock a “buy” rating in a research note on Friday. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $129.75.

Insider Buying and Selling

In other Plexus news, Director Karen Marie Rapp sold 500 shares of the business’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $128.02, for a total value of $64,010.00. Following the completion of the transaction, the director now directly owns 9,586 shares in the company, valued at approximately $1,227,199.72. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, insider Steven J. Frisch sold 6,565 shares of the stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $128.11, for a total transaction of $841,042.15. Following the completion of the sale, the insider now owns 36,118 shares in the company, valued at approximately $4,627,076.98. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Karen Marie Rapp sold 500 shares of the business’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $128.02, for a total value of $64,010.00. Following the transaction, the director now owns 9,586 shares in the company, valued at approximately $1,227,199.72. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 20,113 shares of company stock worth $2,541,394 in the last three months. 2.39% of the stock is owned by insiders.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.